GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,947,000 | -87.6% | 45,143 | -87.6% | 2.39% | +134.2% |
| Q2 2016 | $15,730,000 | +2.5% | 362,947 | -4.1% | 1.02% | +10.2% |
| Q1 2016 | $15,346,000 | -2.8% | 378,469 | -3.2% | 0.93% | 0.0% |
| Q4 2015 | $15,782,000 | +0.7% | 391,129 | -4.0% | 0.93% | +19.9% |
| Q3 2015 | $15,667,000 | -9.2% | 407,454 | -1.7% | 0.77% | +3.2% |
| Q2 2015 | $17,257,000 | +97.2% | 414,339 | +8.5% | 0.75% | +112.2% |
| Q1 2015 | $8,750,000 | -59.9% | 381,930 | -25.2% | 0.35% | -60.2% |
| Q4 2014 | $21,832,000 | -13.0% | 510,815 | -6.4% | 0.89% | -4.2% |
| Q3 2014 | $25,084,000 | -16.3% | 545,668 | -2.6% | 0.92% | -8.9% |
| Q2 2014 | $29,967,000 | -5.4% | 560,331 | -5.5% | 1.02% | +28.2% |
| Q1 2014 | $31,665,000 | -8.4% | 592,639 | -8.5% | 0.79% | -7.6% |
| Q4 2013 | $34,575,000 | +27.2% | 647,590 | +19.5% | 0.86% | +18.2% |
| Q3 2013 | $27,187,000 | -37.3% | 541,893 | -37.6% | 0.72% | -44.3% |
| Q2 2013 | $43,367,000 | – | 867,863 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |